Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL)
RIGL Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
0.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
52.60%
RIGL Stock Analysis
RIGL
PE Ratio:
1.6
RIGL
PEG Ratio:
-0.2
RIGL
Forward EPS Growth (12 month):
-7.00%
RIGL
PS Ratio:
1.9
RIGL
PSG Ratio:
0.1
RIGL
Forward Revenue Growth (12 month):
16.50%
RIGL Articles
No data was found